Rejigged deal gives Schering-Plough Japan taribavirin option
02 June 2009
Ian Haydock
Please Login to read the full article.
02 June 2009
Ian Haydock
ian.haydock@informa.com
Valeant Pharmaceuticals International has granted Schering-Plough an exclusive option to acquire sole development and commercialisation rights in Japan to its antiviral candidate taribavirin.
As part of the deal, Schering-Plough has agreed to waive a last right of refusal to taribavirin...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
